Have a personal or library account? Click to login
Protective role of quercetinum in mercury exposure cardiotoxity Cover

Protective role of quercetinum in mercury exposure cardiotoxity

Open Access
|Jul 2019

References

  1. 1. Omelchuk ST, Aleksijchuk VD, Sokurenko LM, Blagaia A, Prudchenko S. Characteristics of rat liver exposed to nanoparticles of lead compounds. Georgian Med News. 2016;261:94-9.
  2. 2. Omel’chuk ST, Aleksiĭchuk VD, Sokurenko LM. Biochemical parameters of blood and morpho-functional state of the liver of experimental animals by the actions of lead sulfide nanoparticles in different time study. Likars’ka sprava. 2014;3-4:114-8.
  3. 3. Busch J. Knödler M, Kühn M, Lipinski A, Steinhoff B. The heavy metals cadmium, lead and mercury in raw materials of animal origin: evaluation of data from practice. Pharmeur Bio Sci Notes. 2015;2015:150-65.
  4. 4. Aleksiichuk V, Omelchuk S, Sokurenko L, Kaminsky R, Kovalchuk O, Chaikovsky Y. The influence of lead nanoparticles on the morpho-functional changes of rat liver during the postexposure period. Microsc Res Tech. 2018;81:781-788. doi: 10.1002/jemt.23036.10.1002/jemt.2303629652104
  5. 5. Lavrinenko VE, Zinabadinova SS, Shobat LB, Sokurenko LM, Chaikovsky YuB. Influence of nanodiamonds and carbon nanowires on survival and cells structure in chicken embryo. Georgian Medical News. 2016;6(255):93-9.
  6. 6. Rizzetti, DA, da Silva TM, Escobar AG, et al. Mercury-induced vascular dysfunction is mediated by angiotensin II AT-1 receptor upregulation. Environ Res. 2018;162:287-96, doi: 10.1016/j.envres.2018.01.026.10.1016/j.envres.2018.01.02629407760
  7. 7. Bernhoft RA. Mercury toxicity and treatment: a review of the literature. J Environ Public Health. 2012;2012: 460508. doi: 10.1155/2012/460508.10.1155/2012/460508325345622235210
  8. 8. Foras LD. Quercetin in treatment of cardio-vascular diseases. The radical Research. 2005;39:1052-76.
  9. 9. Li G, Zhang H, Li Y, Wang Y. Protection of vascular endothelial cells from high glucose injury induced by quercetin. Zhong Yao Cai. 2002;25(4):268-70.
  10. 10. Sokurenko LM, Chaikovskii YuB. Mildronate protects neuroblasts against toxic inf luence of mercuric chloride in cell culture. Neurophysiology, 2014;46(3):271-3. https://doi.org/10.1007/s11062-014-9440-710.1007/s11062-014-9440-7
  11. 11. Sokurenko LM, Chaikovskii YuB. Protective ef fects of Thiotriazolinum and Mildronate against mercury chloride toxicity in neuroblastoma cell culture Neurophysiology 2016;48(3):171-5. https://doi.org/10.1007/s11062-016-9585-7 . Available from: http://link.springer.com/article/10.1007/s11062-016-9585-710.1007/s11062-016-9585-7
  12. 12. Sokurenko LM, Savchyna MO, Litus VI, Kaminsky RF, Сhaikovsky YB. Rat spinal ganglia in assessment of protective action of antioxidants: A morphological study Medicina (Kaunas). 2017;53(4): 217-23. https://doi.org/10.1016/j.medici.2017.11.00110.1016/j.medici.2017.11.00129273287
  13. 13. Jain AK, Mehra NK, Swarnakar NK. Role of Antioxidants for the Treatment of Cardiovascular Diseases: Challenges and Opportunities. Curr Pharm Des. 2015;21(30):4441-55.10.2174/138161282166615080315175826234792
  14. 14. Maksutina NP. Antioxidant Properties of Quercetin. Pharm J. 1993;6:42-3.
  15. 15. Pierce E. Histochemistry theoretical and applied. M. Foreign Literature; 1962.
  16. 16. Kamynsky R, Primachenko V, Sokurenko L, Chaikovsky Y. A study of impact of mercury chloride on myocardium in experiment. Georgian Med News. 2016;251:64-70.
  17. 17. Avtandilov GG. Fundamentals of quantitative pathological anatomy. Moscow, Meditsina Publ, 2002;240 p.
  18. 18. Chekman IS. Clinical herbal medicine. Kyiv: Kolos;1993:383.
  19. 19. Toronchenko OM, Istomin FM. Application of quercetin in the complex treatment of patients with coronary heart disease with concomitant dyscirculatory encephalopathy. Materials of the III Republican Scientific and Practical Conference «New in Clinical Pharmacology and Pharmacotherapy of Diseases of Internal organs» Kharkiv. 2000;127-9.
  20. 20. Ballmann C, Hollinger K, Selsby JT, Amin R, Quindry JC. Histological and biochemical outcomes of cardiac pathology in mdx mice with dietary quercetin enrichment. Exp Physiol. 2015;100(1):12-22.10.1113/expphysiol.2014.08336025557727
  21. 21. Dovgan RS, Chekman IS. Morphological changes of hypertension rat myocardium at antihypertensive and metabolic pharmacocorrection. Modern science – moderni veda. 2015;2:168-73.
  22. 22. Vatutin NT, Zakhama S. The role of quercetin in preventing the onset of silent myocardial ischemia due to the chronic cardiotoxic effects of anthracycline antibiotics. Questions of Experimental and Clinical Medicine. 2007;11(1):14-8.
  23. 23. Kaminsky F. Rostislav, Sokurenko M. Liudmyla, Chaikovsky B. Yuri Status of rats myocardium under subchronic mercury exposure and its pharmacological correction. Curr Issues Pharm Med Sci., 2016;29(4):167-70.10.1515/cipms-2016-0035
DOI: https://doi.org/10.2478/cipms-2019-0012 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Language: English
Page range: 63 - 66
Submitted on: Apr 28, 2018
|
Accepted on: Nov 22, 2018
|
Published on: Jul 2, 2019
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 Rostyslav F. Kaminsky, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.